Primary immunodeficiency

Revision as of 15:54, 21 September 2012 by Charmaine Patel (talk | contribs)
Jump to navigation Jump to search

Primary immunodeficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary immunodeficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary immunodeficiency On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary immunodeficiency

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary immunodeficiency

CDC on Primary immunodeficiency

Primary immunodeficiency in the news

Blogs on Primary immunodeficiency

Directions to Hospitals Treating Primary immunodeficiency

Risk calculators and risk factors for Primary immunodeficiency

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Examples

Incidence

It is believed that around one in every 1200 Americans has a Primary Immunodeficiency disorder. Conditions - there are over 130 recognised primary immunodeficiencies - common variable immunodeficiency, IgA deficiency, XLA, XLP all being worthy of mention in addition to those listed.

Patient support - there are a growing number of national patient organisations around the world to support those who are diagnosed or where one of the conditions are recorded in a family. Access via www.ipopi.org or e-mail info@ipopi.org [or] The Immune Deficiency Foundation [or] Jeffrey Modell Foundation (Links found under "External Links Section")

Treatment

Primary immunodeficiency is generally treated by immunotherapy either through intravenous infusions of immunoglobulin (IVIG) in an effort to induce passive immunity (Immunotherapy is not indicated for those who are IgA deficient). A new subcutaneous treatment (SC-Ig) was recently approved by the FDA, which is especially recommended in cases of severe adverse effects to the IV-Ig treatment or with individuals with poor venous access. Persons with immunodeficiencies are very vulnerable to opportunistic infections, and the use of antimicrobial agents, such as antibiotics and antifungals, is often required. One of the future prospects in the treatment primary immunodeficiency is gene therapy. However, this form of treatment is in its infancy, and the feasibility and long-term complications of gene therapy are not known.

Along with physical treatment, there are hotlines and patient groups; this enables support for family members as well as the actual patient. One can find a diversity of supports by clicking the link to the 'Immune Deficiency Foundation' or 'Jeffrey Modell Foundation under Wikipedia's section External Links on this page.

External links

Immune Deficiency Foundation [2]

Primary Immunodeficiency Resource Center Presented by the Jeffrey Modell Foundation Jeffrey Modell Foundation

International Patient Organisation for Primary Immunodeficiencies (IPOPI) [3]

Population Prevalence of Diagnosed Primary Immunodeficiency Diseases in the United States [4]

Template:SIB


Template:WikiDoc Sources